Influenza Vaccine Technology Transfer: A Mixed-Methods Study with Vaccine Manufacturers and Global Experts to Assess Successes, Challenges, and Opportunities.

Vaccines (Basel) · 2026 · PMC13308326 · PMID 42347643

Europe PMC DOI

hedged sentence

0.0560

closest p · 1.1× alpha

0.0560

boldest claim

The sentences

marginally non-significantp = 0.056so close (0.05 < p ≤ 0.1)

“Adherence to ethical standards” had a marginally non-significant difference ( p = 0.056), with mean ranks showing that manufacturers tended to rank it as more important than experts.

also in 1,493 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.